The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (stock symbol: ABBV) dividend yield (TTM) as of October 18, 2024 : 2.47%Average dividend yield, last 5 years: 3.98%